Clinical Trial

Quality of Life and Sexuality After Pelvic Exenteration for Gynecologic Cancer

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
Pelvic exenteration is an exceptionally extensive and very rare surgical procedure, most commonly used in the treatment of locally recurrent cervical cancer among gynecological malignancies. It is typically performed with curative intent when no other treatment options remain feasible. The aim of this study is to examine the quality of life and sexuality of patients who have undergone pelvic exenteration. This observational cross-sectional study utilizes internationally validated questionnaires assessing quality of life and sexual function: EORTC QLQ-C30, EORTC QLQ-CX24, and PISQ-12. The findings of this study will provide important guidance for the selection and planning of pelvic exenteration. Improved understanding of postoperative quality of life will support patient selection and enable more comprehensive and individualized patient counseling.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-12.
Trial Details
NCT Number NCT07594327
Lead Sponsor Tampere University Hospital
Conditions Cervical Cancers, Vaginal Cancers, Vulvar Cancers, Endometrial Cancer, Gynecologic Cancers
Enrollment 21 participants
Start Date 2026-05
Primary Completion 2026-10 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2026-05-22